Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Why some depressive patients perform suicidal acts and others do not.

Akechi T, Kato T, Fujise N, Yonemoto N, Tajika A, Furukawa TA; SUN☺D Investigators.

Psychiatry Clin Neurosci. 2019 Jul 29. doi: 10.1111/pcn.12918. [Epub ahead of print] No abstract available.

PMID:
31355505
2.

Predicting relapse in major depression after successful initial pharmacological treatment.

Akechi T, Mantani A, Kurata K, Hirota S, Shimodera S, Yamada M, Inagaki M, Watanabe N, Kato T, Furukawa TA; SUND Investigators.

J Affect Disord. 2019 May 1;250:108-113. doi: 10.1016/j.jad.2019.03.004. Epub 2019 Mar 5.

PMID:
30851699
3.

Dropouts in an Antidepressant Trial: How Do They Fare Afterwards?

Furukawa TA, Kato T, Akechi T, Shimodera S, Okada N, Yanai I, Ozaki K, Kinou K.

Psychother Psychosom. 2018;87(6):380-382. doi: 10.1159/000492434. Epub 2018 Aug 21. No abstract available.

PMID:
30130796
4.

Optimising first- and second-line treatment strategies for untreated major depressive disorder - the SUN☺D study: a pragmatic, multi-centre, assessor-blinded randomised controlled trial.

Kato T, Furukawa TA, Mantani A, Kurata K, Kubouchi H, Hirota S, Sato H, Sugishita K, Chino B, Itoh K, Ikeda Y, Shinagawa Y, Kondo M, Okamoto Y, Fujita H, Suga M, Yasumoto S, Tsujino N, Inoue T, Fujise N, Akechi T, Yamada M, Shimodera S, Watanabe N, Inagaki M, Miki K, Ogawa Y, Takeshima N, Hayasaka Y, Tajika A, Shinohara K, Yonemoto N, Tanaka S, Zhou Q, Guyatt GH; SUN☺D Investigators.

BMC Med. 2018 Jul 11;16(1):103. doi: 10.1186/s12916-018-1096-5.

5.

Behavioral activation: Is it the expectation or achievement, of mastery or pleasure that contributes to improvement in depression?

Furukawa TA, Imai H, Horikoshi M, Shimodera S, Hiroe T, Funayama T, Akechi T; FLATT Investigators.

J Affect Disord. 2018 Oct 1;238:336-341. doi: 10.1016/j.jad.2018.05.067. Epub 2018 Jun 6.

PMID:
29906719
6.

Lithium levels in tap water and psychotic experiences in a general population of adolescents.

Shimodera S, Koike S, Ando S, Yamasaki S, Fujito R, Endo K, Iijima Y, Yamamoto Y, Morita M, Sawada K, Ohara N, Okazaki Y, Nishida A.

Schizophr Res. 2018 Nov;201:294-298. doi: 10.1016/j.schres.2018.05.019. Epub 2018 Jun 9.

PMID:
29895414
7.

Decreased serum pyridoxal levels in schizophrenia: meta-analysis and Mendelian randomization analysis.

Tomioka Y, Numata S, Kinoshita M, Umehara H, Watanabe SY, Nakataki M, Iwayama Y, Toyota T, Ikeda M, Yamamori H, Shimodera S, Tajima A, Hashimoto R, Iwata N, Yoshikawa T, Ohmori T.

J Psychiatry Neurosci. 2018 May;43(3):194-200.

8.

Retraction: A significant causal association between C-reactive protein levels and schizophrenia.

Inoshita M, Numata S, Tajima A, Kinoshita M, Umehara H, Nakataki M, Ikeda M, Maruyama S, Yamamori H, Kanazawa T, Shimodera S, Hashimoto R, Imoto I, Yoneda H, Iwata N, Ohmori T.

Sci Rep. 2018 Feb 21;8:46947. doi: 10.1038/srep46947.

9.

Decreased serum pyridoxal levels in schizophrenia: meta-analysis and Mendelian randomization analysis.

Tomioka Y, Numata S, Kinoshita M, Umehara H, Watanabe SY, Nakataki M, Iwayama Y, Toyota T, Ikeda M, Yamamori H, Shimodera S, Tajima A, Hashimoto R, Iwata N, Yoshikawa T, Ohmori T.

J Psychiatry Neurosci. 2018 Feb 2;43(2):170053. doi: 10.1503/jpn.170053. [Epub ahead of print]

10.

Cognitive and Behavioral Skills Exercises Completed by Patients with Major Depression During Smartphone Cognitive Behavioral Therapy: Secondary Analysis of a Randomized Controlled Trial.

Furukawa TA, Horikoshi M, Fujita H, Tsujino N, Jinnin R, Kako Y, Ogawa S, Sato H, Kitagawa N, Shinagawa Y, Ikeda Y, Imai H, Tajika A, Ogawa Y, Akechi T, Yamada M, Shimodera S, Watanabe N, Inagaki M, Hasegawa A.

JMIR Ment Health. 2018 Jan 11;5(1):e4. doi: 10.2196/mental.9092.

11.

De novo non-synonymous TBL1XR1 mutation alters Wnt signaling activity.

Nishi A, Numata S, Tajima A, Zhu X, Ito K, Saito A, Kato Y, Kinoshita M, Shimodera S, Ono S, Ochi S, Imamura A, Kurotaki N, Ueno SI, Iwata N, Fukui K, Imoto I, Kamiya A, Ohmori T.

Sci Rep. 2017 Jun 6;7(1):2887. doi: 10.1038/s41598-017-02792-z.

12.

Sex differences in auditory verbal hallucinations in early, middle and late adolescence: results from a survey of 17 451 Japanese students aged 12-18 years.

Morokuma Y, Endo K, Nishida A, Yamasaki S, Ando S, Morimoto Y, Nakanishi M, Okazaki Y, Furukawa TA, Morinobu S, Shimodera S.

BMJ Open. 2017 Jun 1;7(5):e015239. doi: 10.1136/bmjopen-2016-015239.

13.

Preference for Solitude, Social Isolation, Suicidal Ideation, and Self-Harm in Adolescents.

Endo K, Ando S, Shimodera S, Yamasaki S, Usami S, Okazaki Y, Sasaki T, Richards M, Hatch S, Nishida A.

J Adolesc Health. 2017 Aug;61(2):187-191. doi: 10.1016/j.jadohealth.2017.02.018. Epub 2017 Apr 27.

14.

Lithium Levels in Tap Water and the Mental Health Problems of Adolescents: An Individual-Level Cross-Sectional Survey.

Ando S, Koike S, Shimodera S, Fujito R, Sawada K, Terao T, Furukawa TA, Sasaki T, Inoue S, Asukai N, Okazaki Y, Nishida A.

J Clin Psychiatry. 2017 Mar;78(3):e252-e256. doi: 10.4088/JCP.15m10220.

PMID:
28394506
15.

Effect of Clozapine on DNA Methylation in Peripheral Leukocytes from Patients with Treatment-Resistant Schizophrenia.

Kinoshita M, Numata S, Tajima A, Yamamori H, Yasuda Y, Fujimoto M, Watanabe S, Umehara H, Shimodera S, Nakazawa T, Kikuchi M, Nakaya A, Hashimoto H, Imoto I, Hashimoto R, Ohmori T.

Int J Mol Sci. 2017 Mar 14;18(3). pii: E632. doi: 10.3390/ijms18030632.

16.

Appetite loss as a potential predictor of suicidal ideation and self-harm in adolescents: A school-based study.

Kitagawa Y, Ando S, Yamasaki S, Foo JC, Okazaki Y, Shimodera S, Nishida A, Togo F, Sasaki T.

Appetite. 2017 Apr 1;111:7-11. doi: 10.1016/j.appet.2016.12.026. Epub 2016 Dec 21.

PMID:
28011004
17.

The Association of Current Violence from Adult Family Members with Adolescent Bullying Involvement and Suicidal Feelings.

Fujikawa S, Ando S, Shimodera S, Koike S, Usami S, Toriyama R, Kanata S, Sasaki T, Kasai K, Okazaki Y, Nishida A.

PLoS One. 2016 Oct 6;11(10):e0163707. doi: 10.1371/journal.pone.0163707. eCollection 2016.

18.

Sleep Duration Associated with the Lowest Risk of Depression/Anxiety in Adolescents.

Ojio Y, Nishida A, Shimodera S, Togo F, Sasaki T.

Sleep. 2016 Aug 1;39(8):1555-62. doi: 10.5665/sleep.6020.

19.

A significant causal association between C-reactive protein levels and schizophrenia.

Inoshita M, Numata S, Tajima A, Kinoshita M, Umehara H, Nakataki M, Ikeda M, Maruyama S, Yamamori H, Kanazawa T, Shimodera S, Hashimoto R, Imoto I, Yoneda H, Iwata N, Ohmori T.

Sci Rep. 2016 May 19;6:26105. doi: 10.1038/srep26105. Retraction in: Sci Rep. 2018 Feb 21;8:46947.

20.

Association study of polymorphism in the serotonin transporter gene promoter, methylation profiles, and expression in patients with major depressive disorder.

Iga J, Watanabe SY, Numata S, Umehara H, Nishi A, Kinoshita M, Inoshita M, Shimodera S, Fujita H, Ohmori T.

Hum Psychopharmacol. 2016 May;31(3):193-9. doi: 10.1002/hup.2527. Epub 2016 Mar 23.

PMID:
27005686

Supplemental Content

Loading ...
Support Center